PCA3 and prostate carcinoma: A sandwich genoassay for quantification of PCA3, a urinary prostate cancer biomarker, has been developed by introducing alkaline phosphatase as a tracer, through a monovalent labeling system on a tagged hybrid formed onto magnetic beads.